Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Extraordinary general meeting in Biotage - Authorization to the Board

Extraordinary general meeting in Biotage - Authorization to the Board Uppsala 20 July, 2004 The Extraordinary General Meeting of Biotage has today resolved to authorize the Board of Directors to issue new shares not exceeding in total 5,700,000 new shares, with or without deviation from the shareholders' pre-emption rights, to be paid for in cash, through an issue in kind or through set-off. Issues may be made in order to finance company acquisitions or to strengthen the company's capital base and equity/assets ratio. In connection with a directed issue against payment in cash, the

ETTEPLAN OYJ RAISES IT?S SHARE CAPITAL

ETTEPLAN OYJ RELEASE 20 July 2004 14.00 p.m. 1 (1)ETTEPLAN OYJ RAISES IT’S SHARE CAPITAL Etteplan Oyj increases it’s share capital as a consequence of theagreement made on 10.6.2004 to acquire a majority stake in theTimatec AB. The new shares have been entered into Trade Register on20 July 2004. The amount of share capital increase is 6.784,20 eurosand the total amount of the new share capital after the increase is434.245,00 euros. In the direct share issue the total number 67.842 of new shares aretradable from 21 July 2004 onwards. The shares are available for

SaabTech receives order for test and trial of BOL Countermeasures Dispensing System for the Australian Airforce's F-18s

SaabTech receives order for test and trial of BOL Countermeasures Dispensing System for the Australian Airforce's F-18s The Commonwealth of Australia has awarded SaabTech an order for adaptation and flight trials of the BOL Countermeasure Dispensing System for the Royal Australian Air Force's F/A-18 Hornet. "We are proud to be selected to be evaluated on the Australian Air Force's F/A-18 fighters. The order shows that the BOL system is a world leading product well-established in the field of self-protection internationally," says SaabTech's president Björn Erman. The Australian Air Force

Saab Ericsson Space and ALCATEL signs Long Term Agreement for Spacebus Primary Satellite Structures

Saab Ericsson Space and ALCATEL signs Long Term Agreement for Spacebus Primary Satellite Structures Saab Ericsson Space AB in Gothenburg, Sweden, and ALCATEL have signed a Long Term Agreement covering Spacebus 3000 and Spacebus 4000 Primary Satellite Structures - This is our first agreement with ALCATEL covering this product. We are very pleased to conclude that the qualification testing covering extended capabilities of both the SB3000B3 and SB4000C1 has been successfully completed in Linköping, says Jörgen Remmelg, General Manager of the Mechanical Products Division at Saab Ericsson Space.

FORTUM'S DEFERRED TAX LIABILITIES WILL D

Fortum Corporation STOCK EXCHANGE RELEASE 20 July 2004 at 11.25 am 1(1)FORTUM'S DEFERRED TAX LIABILITIES WILL DECREASE BY EUR 43 MILLION On June 30, 2004, the Finnish Parliament passed new tax laws thatinclude, among other things, a reduction in the Finnish corporateincome tax rate from 29 percent to 26 percent from the beginningof tax year 2005. As a result, the deferred tax liabilities of Fortum will decreaseby approximately EUR 43 million net, based on preliminaryanalysis. The exact effect of the change in tax rate for 2004 canonly be calculated at the

Telelogic SYNERGY® Named Industry's Best Application Change Management Tool by Yphise for Third Time Running

Telelogic SYNERGY® Named Industry's Best Application Change Management Tool by Yphise for Third Time Running - SYNERGY Receives "Stand Out" Ratings in All Five Categories - Malmö, SWEDEN - July 19, 2004 - Telelogic (Stockholm Exchange:TLOG), the leading global provider of solutions for advanced software and systems development, today announced Telelogic SYNERGY earned the 2004 Yphise Award for Best Application Change Management software. The award was based on a comprehensive performance and functionality assessment using ISO 9001 certified methodology. SYNERGY has received the award for

REMINDER - INVITATION

SEB Interim report January-June 2004 - presentations   SEB's Interim results, January-June 2004 will be announced on July 27th around noon. The report, presentations and an extensive package of Facts & Figures will be available on www.sebgroup. com It is a pleasure for me to invite you to the following presentations regarding the results.   Tuesday, July 27th Press Conference Lars H Thunell, President & CEO will present and comment upon the Interim results, January-June 2004. The presentation will be held at Kungsträdgårdsgatan 8 in Stockholm,

Telelogic Ranked as the 7th Most Influential Company in Application Development

Telelogic Ranked as the 7th Most Influential Company in Application Development - Computer Business Review concludes Telelogic is a "strong European contender in a field dominated by U.S. companies" - MALMÖ, Sweden and IRVINE, California - July 19, 2004 - Telelogic (Stockholm Exchange: TLOG), the leading global provider of solutions for advanced systems and software development, today announced that Computer Business Review (CBR) has included Telelogic in its ranking of the 10 most influential companies in application development for 2004. Last year, Telelogic ranked ninth in CBR's 2003 top

Sharp rise in sales of core niche products

Sharp rise in sales of core niche products SSAB today presented its results for the first half of 2004. Profit after financial items increased by SEK 905 million to SEK 1,685 (780) million. - The result for the first half of the year is the best since 1995 and the second best ever. The strong result also entails that cash flow increased significantly and amounted to SEK 900 (37) million, notes CEO Anders Ullberg in a comment on the report. Demand for steel in Europe continues to increase at a moderate rate and demand for the core niche products, extra and ultra high-strength sheet as well

Half Year Report 2004

Half Year Report 2004 · Sales during the first half of the year increased by 16% and amounted to SEK 12,053 (10,378) million. Profit after tax increased to SEK 1,170 (543) million, equal to earnings per share of SEK 11.60 (5.40). · Profit after financial items for the second quarter increased by SEK 596 million to SEK 962 (366) million. Thus, during the first half of the year profit after financial items has increased by SEK 905 million to SEK 1,685 (780) million. · Deliveries of extra and ultra high-strength sheet and quenched steels during the second quarter were 35% higher than last year

Second quarter 2004

Half Year Report 2004Sales during the first half of the year increased by 16% and amounted to SEK 12,053 (10,378) million. Profit after tax increased to SEK 1,170 (543) million, equal to earnings per share of SEK 11.60 (5.40).Profit after financial items for the second quarter increased by SEK 596 million to SEK 962 (366) million. Thus, during the first half of the year profit after financial items has increased by SEK 905 million to SEK 1,685 (780) million.Deliveries of extra and ultra high-strength sheet and quenched steels during the second quarter were 35% higher than last year

World's largest nickel producer orders major equipment package from Atlas Copco

World's largest nickel producer orders major equipment package from Atlas Copco Stockholm, Sweden, July 19, 2004: Russia's MMC Norilsk Nickel Group, the world's largest producer of nickel and palladium, is to make another major addition to its huge fleet of Atlas Copco equipment currently at work in Russian mines. The order, worth around MEUR 9 (over MSEK 80), is for nine face drilling rigs, ten loaders and one mine truck. The 20 new units will serve five mines, as well as a copper plant. They will supplement the company's existing fleet of over 200 Atlas Copco units. According to MMC

Skanska sells property in Budapest for SEK 618 M, with a gain of SEK 261 M

Skanska sells property in Budapest for SEK 618 M, with a gain of SEK 261 M Skanska is selling the office property Science Park in Budapest for SEK 618 M (EUR 67.5 M). The capital gain amounts to SEK 261 M (EUR 28.5 M) and will be reported during the third quarter of 2004. The buyer is the German fund management company SachsenFonds Gmbh, linked to LandesBank Sachsen GiroCentrale. Science Park is attractively located on the south Buda side of Budapest. The property comprises floor space of 30,000 square meters and was developed by Skanska in two stages. The second stage was completed in July

Invitation for Telephone conference Nobia's Interim Report January - June 2004

Nobia's Interin Report for the preiod January-June 2004 will be published on 22 July 2004. The report is presented and commented by CEO Fredrik Cappelen och CFO Jan Johansson at a Telephone conference for the financial market and the media. The conference will be held in English.   Date: 22 July 2004 Time: 3.00 p.m. CET Call-in number: +44 (0) 20 7162 0185       The conference will also be streamed on the website: www.nobia.se.   The Interim Report and the presentation will be available at the website.       Nobia AB 19 July 2004

HALF-YEAR REPORT JANUARY - JUNE 2004

HALF-YEAR REPORT JANUARY - JUNE 2004 · Biacore's sales in the second quarter 2004 declined by 25% to SEK 107.3 million (142.5). Sales in Europe continued to increase at a healthy rate, but after two quarters of positive sales development in the Americas, orders from the pharmaceutical industry were again disappointing in this quarter. This coincided with continued delays in academic funding in Japan. Sales in the first half-year 2004 fell by 19% to SEK 202.6 million (249.0). Excluding the impact of exchange rates, sales fell by 10% in the first half of 2004. · Biacore incurred a loss of SEK

Ulf Jönsson leaves Biacore, Erik Walldén appointed new President and CEO.

Ulf Jönsson leaves Biacore, Erik Walldén appointed new President and CEO. Uppsala, Sweden, July 19, 2004. Biacore International AB (Biacore) (Stockholmsbörsen: BCOR;) today announced that an agreement has been made between the Board of Biacore International AB and Dr Ulf Jönsson to the effect that Ulf Jönsson will leave his position as President and CEO with immediate effect. He also resigns from the Board of Directors. Pending permission from the Companies Registration Office, the Board has appointed Mr Erik Walldén, at present Executive Vice President and Head of marketing and business

Wihlborgs has acquired a further 3.1 percent of the shares in Fabege and is submitting a public offer

Wihlborgs has acquired a further 3.1 percent of the shares in Fabege and is submitting a public offer The Offer is not aimed at persons whose participation presupposes further prospectuses, registration measures or measures other than those that follow Swedish law. Through this press release no offer is submitted, directly or indirectly, in the USA or Canada. The press release may not be distributed to countries where the distribution or the Offer call for measures that are in accordance with the previous paragraph or that violate against regulations in such a country. - Wihlborgs has

Eniro: CEO's comments

After six weeks at Eniro and after having completed the situation assessment, I have now entered a planning stage and am concentrating on how to address the negative trend in Sweden, reviewing Eniro's overall strategy, working with the capital structure and planning for a new organization. The results will be announced at a Capital Market Day during the fall.I have identified a number of strategic initiatives, of which some are more general and others of an operative nature. These include the following: - strengthening Eniro's core markets Sweden and Finland, which will require a review of

Eniro - Interim report: January - June 2004

April - June - Operating revenues increased 2% to SEK 1,324 M (1,300) - Operating income before depreciation (EBITDA) increased by 4% to SEK 404 M (388) - Net income for the period increased 12% to SEK 168 M (150) - Net income per share increased 18% to SEK 1.00 (0.85) - New sales for offline products in Sweden continue to decline at the same rate as offline revenues during the first half of 2004 - Tomas Franzén new President and CEO from June 1 January - June - Operating revenues increased 7% to SEK 2,191 M (2,051) - Operating income before depreciation (EBITDA) increased by 2% to SEK 603

Atlas Copco - Capital Markets Day 2004

Atlas Copco - Capital Markets Day 2004 Stockholm, Sweden, July 16 2004: Atlas Copco invites you to our Capital Markets Day 2004 on Tuesday September 21. The purpose of the day is to give an update on the strategy and development of the Atlas Copco Group and also to cover a specific theme. This time we want to focus on the Construction and Mining Technique business area and use this meeting to give you a more in-depth look at our activities in this business. The Capital Markets Day will be held in Örebro, located some two hours west of Stockholm, and home of Atlas Copco's Rock Excavation

Skanska sells Rosengård Center in Malmö for SEK 315 M, with a gain of SEK 55 M

Skanska sells Rosengård Center in Malmö for SEK 315 M, with a gain of SEK 55 M Skanska Project Development Sweden is selling the property Landshövdingen 1 (Rosengård Center) in Malmö for SEK 315 M to Erik Selin. The capital gain amounts to SEK 55 M and will be reported in the third quarter of 2004. The buyer gains access of the property on July 16, 2004 when payment will be made. The property consists of both a municipal office serving local residents and a shopping center. Of floor space totaling 33,000 square meters, some 20,000 square meters is retail space. Rosengård Center has

Medivir & Biovitrum Initiate Research Collaboration in Diabetes

Medivir & Biovitrum Initiate Research Collaboration in Diabetes Medivir and Biovitrum today announce that they initiate a research collaboration to meet the significant and growing medical need in type 2 diabetes. The intent of the collaboration is to combine the strengths of the two companies and develop a candidate drug for type 2 diabetes. Biovitrum is specializing in metabolic diseases and has ongoing clinical and preclinical research programs in this area. Medivir has superior protease expertise and technologies that complement this research. "We have identified the metabolic area as

There are no items matching the current filter
There are no more items matching the current filter
Back to top